4.8 Article

Stable black phosphorus/Bi2O3 heterostructures for synergistic cancer radiotherapy

Journal

BIOMATERIALS
Volume 171, Issue -, Pages 12-22

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2018.04.022

Keywords

Black phosphorus; 2D Layered materials; Radiotherapy; Photodynamic effect; Cancer therapy

Funding

  1. National Natural Science Fund of China [51672305, 21701051]
  2. National Program for Support of Top-notch Young Professionals [W02070191]
  3. Frontier Science Key Programs of Chinese Academy of Sciences [QYZDB-SSW-SLH034]
  4. Shenzhen Science and Technology Research Funding [JCYJ20160229195124187]
  5. Guangdong Frontier Key Technological Innovation Special Funds [20148050505012]
  6. Fundamental Research Funds for the Central Universities
  7. China Postdoctoral Science Foundation [2016M600705]
  8. Natural Science Foundation of Guangdong Province [2017A030313051]
  9. Leading Talents of Guangdong Province Program [00201520]

Ask authors/readers for more resources

X-ray induced photodynamic therapy (X-ray-PDT) is a promising approach for synergistic cancer radiotherapy and development of suitable radiosensitizers is highly desired. In this paper, we propose black phosphorus/Bi2O3 (BP/Bi2O3) heterostructures as efficient and biocompatible radiosensitizers for synergistic cancer radiotherapy. The heterostructures are synthesized by growth of ultrasmall Bi2O3 nanoparticles onto BP nanosheets. The Bi2O3 decoration inhibits the rapid degradation of BP nanosheets by occupation of the defect sites, and the synergistic effects of BP and Bi2O3 enable O-1(2) overproduction under X-ray irradiation. This X-ray-PDT effect of the BP/Bi2O3 nanosheets enhances the radiotherapy activity towards cancer cells by inducing cell apoptosis and cycle arrest. In vivo treatment of melanoma conducted on a clinical radiotherapeutic instrument demonstrates that the BP/Bi2O3 sensitized radio-therapy inhibits tumor growth efficiently. Furthermore, the BP/Bi2O3 nanosheets composed of biological friendly P, O, and Bi elements shows good biocompatibility in vitro and in vivo. This radiosensitizer thus has immense clinical potential for cancer therapy, and our findings reveal a general strategy to fabricate stable BP-based heterostructures for different applications. (C) 2018 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available